These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 7697574)

  • 41. Morning resistance to thrombolytic therapy.
    Braunwald E
    Circulation; 1995 Mar; 91(5):1604-6. PubMed ID: 7867204
    [No Abstract]   [Full Text] [Related]  

  • 42. Prevention of severe neurologic events in the thrombolytic era.
    Gore JM
    Chest; 1992 Apr; 101(4 Suppl):124S-130S. PubMed ID: 1555477
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Issues in extrapolating from clinical trials to clinical practice and outcomes.
    Tonkin AM
    Aust N Z J Med; 1998 Aug; 28(4):574-8. PubMed ID: 9777143
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Thrombolytic therapy of acute myocardial infarction: trials, trials, and more trials.
    Conti CR
    Clin Cardiol; 1991 Apr; 14(4):281-2. PubMed ID: 2032404
    [No Abstract]   [Full Text] [Related]  

  • 45. Industry perspective on ISIS-3 results.
    Can J Cardiol; 1991 Apr; 7(3):VIII. PubMed ID: 2044010
    [No Abstract]   [Full Text] [Related]  

  • 46. Achieving excellence in thrombolytic therapy.
    Whitcomb R; Aleman D
    J Healthc Qual; 1995; 17(3):23-5, 38. PubMed ID: 10142165
    [TBL] [Abstract][Full Text] [Related]  

  • 47. What is the likely benefit of earlier thrombolysis?
    Rawles J
    Eur Heart J; 1996 Jul; 17(7):991-5. PubMed ID: 8809514
    [No Abstract]   [Full Text] [Related]  

  • 48. Thrombolytic therapy in acute myocardial infarction--current issues and strategies. Introduction and summary.
    Zweifler A
    Clin Cardiol; 1997 Nov; 20(11 Suppl 3):III1, III32. PubMed ID: 9453881
    [No Abstract]   [Full Text] [Related]  

  • 49. Clinical trials and clinical practice.
    Norris RM; Roy S; Dixon GF
    Lancet; 1993 Nov; 342(8883):1366. PubMed ID: 7901658
    [No Abstract]   [Full Text] [Related]  

  • 50. Construction of a literature database and its use to provide probabilities for decision-analytic models of thrombolytic therapy.
    Murphy JF; Jain NL; Romero CA; Kahn MG
    Proc Annu Symp Comput Appl Med Care; 1994; ():819-23. PubMed ID: 7950039
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Management of acute myocardial infarction.
    Turner M
    Postgrad Med J; 1996 May; 72(847):318. PubMed ID: 8761516
    [No Abstract]   [Full Text] [Related]  

  • 52. Thrombolytic therapy for elderly patients with myocardial infarction.
    Dave S
    JAMA; 1997 Nov; 278(17):1401; author reply 1401-2. PubMed ID: 9355989
    [No Abstract]   [Full Text] [Related]  

  • 53. [Economic lessons of large-scale thrombolytic trials].
    Beaufils P; Blum-Boisgard C; Geffroy L; Hazebroucq G; Launois B; Launois R; Leclercq B; Viens-Bitker C
    Arch Mal Coeur Vaiss; 1989 Oct; 82 Spec No 3():63-8. PubMed ID: 2512890
    [No Abstract]   [Full Text] [Related]  

  • 54. Clinical pharmacology and therapeutics.
    Breckenridge A
    BMJ; 1995 Feb; 310(6976):377-80. PubMed ID: 7866217
    [No Abstract]   [Full Text] [Related]  

  • 55. Clinical judgment is not passé when it comes to identifying patients with acute myocardial infarction.
    Hess EP
    Evid Based Med; 2016 Jun; 21(3):117. PubMed ID: 27095605
    [No Abstract]   [Full Text] [Related]  

  • 56. Leeches, snakes, ticks, and vampire bats in today's cardiovascular drug development.
    Bang NU
    Circulation; 1991 Jul; 84(1):436-8. PubMed ID: 2060117
    [No Abstract]   [Full Text] [Related]  

  • 57. A method of assigning scores to the components of a composite outcome: an example from the MITI trial.
    Hallstrom AP; Litwin PE; Weaver WD
    Control Clin Trials; 1992 Apr; 13(2):148-55. PubMed ID: 1316829
    [TBL] [Abstract][Full Text] [Related]  

  • 58. New Thrombolytic Infusion Application of Dissolving Renal Artery Embolic Thrombosis: Low-Dose Slow-Infusion Thrombolytic Therapy.
    Karakurt A
    Case Rep Nephrol; 2018; 2018():1609025. PubMed ID: 29854504
    [TBL] [Abstract][Full Text] [Related]  

  • 59. After ISIS-3.
    Sobel BE; Collen D
    Lancet; 1992 May; 339(8803):1225-6; author reply 1226-7. PubMed ID: 1349951
    [No Abstract]   [Full Text] [Related]  

  • 60. Decision analysis in medicine.
    Round A; Marshall A; Backett M
    BMJ; 1992 Jun; 304(6840):1511. PubMed ID: 1611391
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.